Rifampin-Induced Methadone Withdrawal

New England Journal of Medicine

Volumn 294, Issue 20, 1976, Pages 1104-1106

  Kreek, Mary Jeanne ^a   Garfield, Jane W ^a   Gutjahr, Chai Leng ^a   Giusti, Louise M ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; METHADONE; PHENOBARBITAL; RIFAMPICIN;

ABDOMINAL PAIN; ADVERSE DRUG REACTION; ANXIETY; CHILD; DRUG DEPENDENCE; DRUG INTERACTION; DRUG THERAPY; FEVER; NAUSEA; ORAL DRUG ADMINISTRATION; THERAPY; TUBERCULOSIS; WITHDRAWAL SYNDROME;

EID: 0017081996     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197605132942008     Document Type: Article

References (18)

1. Presented in part at the annual meeting of the American Thoracic Society, Montreal, PQ, Canada, May 20, 1975.
2. Nocke-Finck L, Breuer H, Reimers D: Wirkung von Rifampicin auf den Menstruationszyklus und die Östrogenausscheidung bei Einnahme oraler Kontrazeptiva. Dtsch Med Wochenschr 98: 1521–1523, 1973
3. O'Reilly RA: Interaction of sodium warfarin and rifampin: studies in man. Ann Intern Med 81: 337–340, 1974
4. Garfield J: Isoniazid-rifampin for initial treatment of pulmonary tuberculosis: preliminary report of a Public Health Service Cooperative Trial. Am Rev Respir Dis 109: 717, 1974
5. Newman R, Doster BC, Murray FJ, et al: Rifampin in initial treatment of pulmonary tuberculosis: a U.S. Public Health Service Tuberculosis Therapy Trial. Am Rev Respir Dis 109: 216–232, 1974
6. Fox W, Mitchison DA: Short-course chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis 111: 325–353, 1975
7. Snedecor GW, Cochran WG: Statistical Methods. Sixth edition. Ames, Iowa, Iowa State University Press, 1967, pp 91–119
8. Inturrisi CE, Verebely K: The levels of methadone in the plasma in methadone maintenance. Clin Pharmacol Ther 13: 633–637, 1972
9. Kreek MJ: Plasma and urine levels of methadone: comparison following four medication forms used in chronic maintenance treatment. NY State J Med 73: 2773–2777, 1973
10. Sullivan HR, Due SL: Urinary metabolites of dl-methadone in maintenance subjects. J Med Chem 16: 909–913, 1973
11. Hoffman L: A methadone program for addicts with chest disease. JAMA 211: 977–982, 1970
12. Scheuer PJ, Summerfield JA, Lal S, et al: Rifampicin hepatitis: a clinical and histological study. Lancet 1: 421–425, 1974
13. Acocella G, Nicolis FB, Tenconi LT: The effect of an intravenous infusion of rifamycin SV on the excretion of bilirubin, bromsulphalein, and indocyanine green in man. Gastroenterology 49: 521–525, 1965
14. Jezequel AM, Orlandi F, Tenconi LT: Changes of the smooth endoplasmic reticulum induced by rifampicin in human and guinea-pig hepatocytes. Gut 12: 984–987, 1971
15. Kreek MJ, Rothschild MA, Bowen D, et al: Hepatic extraction and metabolism of methadone and other narcotics by the perfused rabbit liver. Gastroenterology 67: 805, 1974
16. Nitti V, Ninni A, Meola G, et al: Comparative investigations of the enzyme-inducing activity of rifampicin and barbiturates in man. Chemotherapy 19: 206–210, 1973
17. Remmer H, Schoene B, Fleischmann RA: Induction of the unspecific microsomal hydroxylase in the human liver. Drug Metab Dispos 1: 224–230, 1973
18. Dole VP, Kreek MJ: Methadone plasma level: sustained by a reservoir of drug in tissue. Proc Natl Acad Sci USA 70: 10, 1973